Clinical Trial Update: Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating radioablation with or without androgen deprivation therapy in oligometastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligometastatic Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Oligometastatic Prostate Cancer | Phase 2 | Status: UNKNOWN